The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2025 | Integrating AI and biomarkers for enhanced lung cancer screening
Deniz Koksal, MD, Hacettepe University, Ankara, Türkiye, discusses the potential of combining artificial intelligence (AI) with biomarkers to enhance lung cancer screening and risk stratification. She highlights how this integrated approach could lead to more cost-effective screening models in the future. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
